Daniel Joseph Apel

Chief Financial Officer, Arrowhead Pharmaceuticals.

Companies

Arrowhead PharmaceuticalsChief financial officer Aug 12, 2025 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Arrowhead Pharmaceuticals ARWR162,905 shares²$9.2M at $56.73Apr 22, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 22, 2026Sold 8,730 shares at $71.92 of Arrowhead Pharmaceuticals²
Apr 22, 2026Sold 1,157 shares at $70.45 of Arrowhead Pharmaceuticals²
Apr 22, 2026Sold 3,208 shares at $70.11 of Arrowhead Pharmaceuticals²
Jan 6, 2026Granted 75,000 shares of Arrowhead Pharmaceuticals³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARArrowhead Pharmaceuticals, Chief financial officer
2
SEC EDGARArrowhead Pharmaceuticals shares after the filing of Apr 22, 2026
3
SEC EDGARForm 4 filed Jan 8, 2026